Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America

Ross Levine (Author)

9781455749416, Elsevier Health Sciences

Hardback, published 10 October 2012

240 pages
28 x 19 x 2.1 cm, 0.4 kg

Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; Role of novel mutations in MPN pathogenesis and outcome; Role of JAK inhibitors in MPN treatment; Animal Models of MPNs; and Role of Germline Genetic Factors in MPN Pathogenesis.

Subject Areas: Oncology [MJCL]